|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1997-9-22
|
|
pubmed:abstractText |
During therapy to relieve congestion in advanced heart failure, cardiac filling pressures can frequently be reduced to near-normal levels with improved cardiac output. It is not known whether the early hemodynamic improvement and drug response can be maintained long term.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0009-7322
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
19
|
|
pubmed:volume |
96
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1165-72
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9286945-Amiodarone,
pubmed-meshheading:9286945-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:9286945-Anti-Arrhythmia Agents,
pubmed-meshheading:9286945-Captopril,
pubmed-meshheading:9286945-Cardiac Output,
pubmed-meshheading:9286945-Diuretics,
pubmed-meshheading:9286945-Drug Therapy, Combination,
pubmed-meshheading:9286945-Female,
pubmed-meshheading:9286945-Heart Failure,
pubmed-meshheading:9286945-Hemodynamics,
pubmed-meshheading:9286945-Humans,
pubmed-meshheading:9286945-Hydralazine,
pubmed-meshheading:9286945-Isosorbide Dinitrate,
pubmed-meshheading:9286945-Male,
pubmed-meshheading:9286945-Middle Aged,
pubmed-meshheading:9286945-Vasodilator Agents,
pubmed-meshheading:9286945-Ventricular Pressure
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.
|
|
pubmed:affiliation |
Ahmanson-UCLA Cardiomyopathy Center, UCLA School of Medicine, Los Angeles, Calif, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
